Placental peroxisome proliferator-activated receptor-γ is up-regulated by pregnancy serum

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 10, 2000, Pages 3808-3814

  Waite, Leslie L ^a   Person, Eric C ^a   Zhou, Yan ^a   Lim, Kee Hak ^b   Scanlan, Thomas S ^a   Taylor, Robert N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CHORIOCARCINOMA; CONTROLLED STUDY; CYTOTROPHOBLAST; DNA RESPONSIVE ELEMENT; GENE CONSTRUCT; HUMAN; HUMAN CELL; MATERNAL SERUM; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 0033763065     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.85.10.6847     Document Type: Article

References (43)

1. Peroxisome proliferator-activated receptors: Three isotypes for a multitude of functions
2. Peroxisome proliferator-activated receptors: A nuclear receptor signaling pathway in lipid physiology
3. Peroxisome proliferator-activated receptor γ and the control of adipogenesis
4. The nuclear receptor PPARγ: Bigger than fat
5. PPARγ, the ultimate thrifty gene
6. PPAR-γ: Adipogenic regulator and thiazolidinedione receptor
7. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors
8. 15-Deoxy-δ12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR γ
9. A prostaglandin J2 metabolite binds the peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation
10. Down regulation of peroxisome proliferator-activated receptor γ expression by inflammatory cytokines and its reversal by thiazolidinediones
11. Negative regulation of peroxisome proliferator-activated receptor-γ gene expression contributes to the antiadipogenic effects of tumor necrosis factor-α
12. TNF-α-mediated inhibition and reversal of adipocyte differentiation is accompanied by suppressed expression of PPARγ without effects on Pref-1 expression
13. Decreased expression of murine PPARγ in adipose tissue during endotoxemia
14. PPARγ is required for placental, cardiac, and adipose tissue development
15. Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARδ
16. 15-Deoxy-δ(12,14)-prostaglandin J(2), a ligand for peroxisome proliferator-activated receptor-γ, induces apoptosis in JEG3 choriocarcinoma cells
17. Peroxisome proliferators and retinoids affect JEG-3 choriocarcinoma cell function
18. Amino acid and protein metabolism in the developing fetus and newborn infant
19. Placental transport of nutrients to the fetus
20. The hyperlipidemia of pregnancy in normal and complicated pregnancies
21. Levels of free fatty acids and arachidonic acid in pregnancy and labor
22. Serum arachidonic acid levels in normal and preeclamptic pregnancies
23. Plasma factors that determine endothelial cell lipid toxicity in vitro correctly identify women with preeclampsia in early and late pregnancy
24. Circulating factors as markers and mediators of endothelial cell dysfunction in preeclampsia
25. Pre-eclampsia: More than pregnancy-induced hypertension
26. Current protocols in molecular biology
27. Studies on antidiabetic agents. XII. Synthesis and activity of the metabolites of (+/-)-5(-)[p(-)[2-(5-ethyl-2-pyridyl)ethoxy]benzyl]-2,4-thiazolidinedione (pioglitazone)
28. Synthesis and biological activity of metabolites of the antidiabetic, antihyperglycemic agent pioglitazone
29. [[ω-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents
30. The synthesis of BRL 49653: A novel and potent antihyperglycaemic agent
31. Cell biology of endothelial cells
32. Adhesive and degradative properties of human placental trophoblasts in vitro
33. 92-kD type IV collagenase mediates invasion of human cytotrophoblasts
34. Glucocorticoid receptor mutants that define a small region sufficient for enhancer activation
35. Human cytotrophoblasts adopt a vascular phenotype as they differentiate: A strategy for successful endovascular invasion?
36. Regulation of PPAR γ gene expression by nutrition and obesity in rodents
37. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors
38. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ)
39. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
40. Differential activation of peroxisome proliferator-activated receptors by eicosanoids
41. Expression of peroxisome proliferator-activated receptor PPARδ promotes induction of PPARγ and adipocyte differentiation in 3T3C2 fibroblasts